Skip to Content

DaVita Inc

DVA: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$797.00RdlgrLpwycmqq

DaVita Turns in Decent Q4 and Guides Cautiously for 2023; No FVE Change

Narrow-moat DaVita turned in fourth-quarter results that were slightly better than we anticipated, allowing it to mildly exceed our 2022 estimates. However, 2023 guidance appears slightly weaker than expected. Those two factors largely offset in our model though, and we expect to maintain our $108 fair value estimate. DaVita shares remain moderately undervalued, in our opinion.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of DVA so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center